P&G to Webcast Discussion of Third Quarter 23/24 Earnings Results on April 19
The Procter & Gamble Company (NYSE:PG) will webcast a discussion of its third quarter earnings results on Friday, April 19, 2024 beginning at 8:30 a.m. ET.
Media and investors may access the live audio webcast at www.pginvestor.com. The webcast will also be available for replay.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
Infrastructure Dividend Split Corp. (the "Company"), is pleased to announce that it has filed a final prospectus in relation to an initial public offering of preferred shares. The maximum amount of the offering is $52,643,700. The Company will...
Aura Minerals Inc. ("Aura" or the "Company") announces that it has filed its unaudited consolidated financial statements and management discussion and analysis (together, "Financial and Operational Results") for the period ended March 31, 2024...
Planned Parenthood of Metropolitan Washington, DC (PPMW) recently received an Underserved Communities Projects grant from Montgomery County, Maryland, to grow the PPMW Promotoras de Salud community health outreach program. The Promotoras de Salud...
WHY: Rosen Law Firm, a global investor rights law firm, reminds those who held the common stock of Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company as of the record date of March 18, 2021 for the merger with the then-private The...
LEEF Brands, Inc. ("LEEF" or the "Company") , a premier vertical cannabis operator, today announces an update regarding the Company's convertible debentures, further to its press release dated April 18, 2024. In a strategic financial restructuring,...
Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
